Showing 71–80 of 80 results from Publika

Boerrigter G, Costello-Boerrigter LC, Cataliotti A, Tsuruda T, Harty GJ, Lapp H, Stasch JP, Burnett JC (2003)
Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure
Circulation, 107 (5), 686-9
PubMed 12578869 DOI 10.1161/01.cir.0000055737.15443.f8
Malatino LS, Cataliotti A, Benedetto FA, Stancanelli B, Bellanuova I, Belluardo P, Bonaiuto L, Tripepi G, Mallamaci F, Castellino P, Zoccali C (2003)
Hepatocyte growth factor and left ventricular geometry in end-stage renal disease
Hypertension, 41 (1), 88-92
PubMed 12511535 DOI 10.1161/01.hyp.0000046919.41112.4b
Tsuruda T, Boerrigter G, Huntley BK, Noser JA, Cataliotti A, Costello-Boerrigter LC, Chen HH, Burnett JC (2002)
Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases
Circ Res, 91 (12), 1127-34
PubMed 12480813 DOI 10.1161/01.res.0000046234.73401.70
Jougasaki M, Larsen AM, Cataliotti A, Christiansen DC, Burnett JC (2002)
Cardiotrophin-1 stimulates endothelin-1 via gp130 in vascular endothelial cells
Peptides, 23 (8), 1441-7
PubMed 12182945 DOI 10.1016/s0196-9781(02)00078-5
Zoccali C, Mallamaci F, Tripepi G, Parlongo S, Cutrupi S, Benedetto FA, Cataliotti A, Malatino LS, CREED investigators (2002)
Norepinephrine and concentric hypertrophy in patients with end-stage renal disease
Hypertension, 40 (1), 41-6
PubMed 12105136 DOI 10.1161/01.hyp.0000022063.50739.60
Zoccali C, Mallamaci F, Maas R, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bellanuova I, Böger R, CREED Investigators (2002)
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients
Kidney Int, 62 (1), 339-45
PubMed 12081596 DOI 10.1046/j.1523-1755.2002.00437.x
Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Stancanelli B, Malatino LS (2002)
Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease
Circulation, 105 (11), 1354-9
PubMed 11901048 DOI 10.1161/hc1102.105261
Tsuruda T, Jougasaki M, Boerrigter G, Huntley BK, Chen HH, D'Assoro AB, Lee SC, Larsen AM, Cataliotti A, Burnett JC (2002)
Cardiotrophin-1 stimulation of cardiac fibroblast growth: roles for glycoprotein 130/leukemia inhibitory factor receptor and the endothelin type A receptor
Circ Res, 90 (2), 128-34
PubMed 11834704 DOI 10.1161/hh0202.103613
Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, Cataliotti A, Bellanuova I, Malatino LS, Soldarini A, CREED Investigators (2002)
Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients
Kidney Int, 61 (2), 609-14
PubMed 11849403 DOI 10.1046/j.1523-1755.2002.00144.x
Castellino P, Cataliotti A (2002)
Changes of protein kinetics in nephrotic patients
Curr Opin Clin Nutr Metab Care, 5 (1), 51-4
PubMed 11790950 DOI 10.1097/00075197-200201000-00010